-+ 0.00%
-+ 0.00%
-+ 0.00%

Rocket Pharmaceuticals Q4 EPS $(0.38) Beats $(0.44) Estimate

Benzinga·02/26/2026 21:03:36
Listen to the news
Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.44) by 13.04 percent. This is a 38.71 percent increase over losses of $(0.62) per share from the same period last year.